Skip to main content
NCBI home page
Gut logoLink to Gut
. 1986 Jan;27(1):86–91. doi: 10.1136/gut.27.1.86

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.

R W Chapman, M Cottone, W S Selby, H A Shepherd, S Sherlock, D P Jewell
PMCID: PMC1433164  PMID: 3485067

Abstract

The aetiology of primary sclerosing cholangitis is unknown, but it is closely associated with ulcerative colitis. Serum anticolon antibodies, crossreacting with portal tracts, have been reported in patients with ulcerative colitis but no studies have been carried out in primary sclerosing cholangitis. The frequency of serum anticolon antibodies and portal tract antibodies have been measured in 24 patients with primary sclerosing cholangitis and ulcerative colitis; 15 patients with primary sclerosing cholangitis without ulcerative colitis; 77 patients without primary sclerosing cholangitis: 25 patients with Crohn's colitis; 10 patients with primary biliary cirrhosis; 22 patients with extrahepatic biliary obstruction and 20 normal controls. Serum anticolon and portal tract antibodies were detected using immunoperoxidase techniques on normal colon and obstructed human liver. Tissue typing was undertaken using a standard microcytotoxicity technique. The frequency of anticolon antibodies was markedly increased in primary sclerosing cholangitis patients with ulcerative colitis (62.5%) compared with patients with ulcerative colitis (17%) and Crohn's colitis (16%) (chi 2 = 17.9; p less than 0.001). The antibodies were almost entirely of IgG and IgA classes in all groups. Anticolon antibodies were not found in sera from any other group. Sera from eight of 15 patients with primary sclerosing cholangitis, ulcerative colitis and anticolon antibody reacted with portal tracts of human obstructed liver. This reaction was also seen in four of nine patients with ulcerative colitis and primary sclerosing cholangitis and in three of 15 patients with primary sclerosing cholangitis alone. Portal tract antibody was of IgG class and was not present in sera from any other groups. Unlike anticolon antibody, there was a close relationship between HLA-B8 phenotype and the portal tract antibody (p<0.02; chi 2 = 6.04). Absorption studies confirmed that the anticolon antibody is distinct from portal tract antibody.

Full text

PDF
86

Images in this article

88Fig. 1
on p.88
89Fig. 2
on p.89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROBERGER O., PERLMANN P. Autoantibodies in human ulcerative colitis. J Exp Med. 1959 Nov 1;110:657–674. doi: 10.1084/jem.110.5.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bodenheimer H. C., Jr, LaRusso N. F., Thayer W. R., Jr, Charland C., Staples P. J., Ludwig J. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology. 1983 Mar-Apr;3(2):150–154. doi: 10.1002/hep.1840030203. [DOI] [PubMed] [Google Scholar]
  3. Brinch L., Teisberg P., Schrumpf E., Akesson I. The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis. Scand J Gastroenterol. 1982 Jun;17(4):523–527. doi: 10.3109/00365528209182243. [DOI] [PubMed] [Google Scholar]
  4. Carter R. L., Gershon R. K., Kondo K. Studies on homotransplantable lymphomas in hamsters. V. The significance of immunofluorescent staining in tissues from tumor-bearing animals. Transplantation. 1968 May;6(3):313–321. [PubMed] [Google Scholar]
  5. Chapman R. W., Arborgh B. A., Rhodes J. M., Summerfield J. A., Dick R., Scheuer P. J., Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980 Oct;21(10):870–877. doi: 10.1136/gut.21.10.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chapman R. W., Varghese Z., Gaul R., Patel G., Kokinon N., Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut. 1983 Jan;24(1):38–41. doi: 10.1136/gut.24.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. De Aizpurua H. J., Cosgrove L. J., Ungar B., Toh B. H. Autoantibodies cytotoxic to gastric parietal cells in serum of patients with pernicious anemia. N Engl J Med. 1983 Sep 15;309(11):625–629. doi: 10.1056/NEJM198309153091102. [DOI] [PubMed] [Google Scholar]
  8. Dobersen M. J., Scharff J. E., Ginsberg-Fellner F., Notkins A. L. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med. 1980 Dec 25;303(26):1493–1498. doi: 10.1056/NEJM198012253032601. [DOI] [PubMed] [Google Scholar]
  9. Eddleston A. L., Williams R. HLA and liver disease. Br Med Bull. 1978 Sep;34(3):295–300. doi: 10.1093/oxfordjournals.bmb.a071515. [DOI] [PubMed] [Google Scholar]
  10. KOFFLER D., MINKOWITZ S., ROTHMAN W., GARLOCK J. Immunocytochemical studies in ulcerative colitis and regional ileitis. Am J Pathol. 1962 Dec;41:733–745. [PMC free article] [PubMed] [Google Scholar]
  11. LaRusso N. F., Wiesner R. H., Ludwig J., MacCarty R. L. Current concepts. Primary sclerosing cholangitis. N Engl J Med. 1984 Apr 5;310(14):899–903. doi: 10.1056/NEJM198404053101407. [DOI] [PubMed] [Google Scholar]
  12. Marcussen H., Nerup J. Fluorescent anti-colon and organ-specific antibodies in ulcerative colitis. Scand J Gastroenterol. 1973;8(1):9–15. [PubMed] [Google Scholar]
  13. McFarlane I. G., Wojcicka B. M., Tsantoulas D. C., Portmann B. C., Eddleston A. L., Williams R. Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases. Gastroenterology. 1979 Jun;76(6):1333–1340. [PubMed] [Google Scholar]
  14. Schrumpf E., Elgjo K., Fausa O., Gjone E., Kolmannskog F., Ritland S. Sclerosing cholangitis in ulcerative colitis. Scand J Gastroenterol. 1980;15(6):689–697. doi: 10.3109/00365528009181516. [DOI] [PubMed] [Google Scholar]
  15. Shepherd H. A., Selby W. S., Chapman R. W., Nolan D., Barbatis C., McGee J. O., Jewell D. P. Ulcerative colitis and persistent liver dysfunction. Q J Med. 1983 Autumn;52(208):503–513. [PubMed] [Google Scholar]
  16. Triger D. R., Alp M. H., Wright R. Bacterial and dietary antibodies in liver disease. Lancet. 1972 Jan 8;1(7741):60–63. doi: 10.1016/s0140-6736(72)90061-x. [DOI] [PubMed] [Google Scholar]
  17. Wright R., Truelove S. C. Auto-immune reactions in ulcerative colitis. Gut. 1966 Feb;7(1):32–40. doi: 10.1136/gut.7.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES